How is our technology driving dramatically faster breast cancer risk recurrence profiling. This is how. lnkd.in/eVt2-Xrt #breastcancer #ai #innovation
Personalised cancer decision-making at an industry transforming speed and price digistain.co.uk
#breastcancer #oncology #pathology
Technology to overcome the time and cost challenges associated with traditional breast cancer recurrence risk testing. Find out more here digistain.co.uk
#breastcancer #innovation
9 startups dont 2 françaises atteignent la finale de l’EIT Health Catapult ! 👇
Domaine #LifeScience :
🇬🇧Celex Oncology
🇳🇱Pan Cancer T
🇫🇷POLYGON Therapeutics
Domaine #HealthTech :
🇸🇪Acorai
🇬🇧digistain
🇩🇪Dymium
🇫🇷Five Lives
🇪🇸nen
🇦🇹Saphenus
Finale les 5-6 juin à Munich
Glad to announce on #worldcancerday digistain will be joining the UK🇬🇧-India 🇮🇳Healthcare Trade Mission (13-17 Feb).
Digistain’s MHRAgovuk approved patented breast cancer grading & prognosis solution is used for hormone receptor positivity risk profiling.
#cancerday2023
DIGISTAIN® – Revolutionary breast cancer risk profiling technology #breastcancer #breastcancer diagnosis #cancerdiagnosis #digistain #digitalhealth #Cancer link.springer.com/article/10.100…
JUST IN: Groundbreaking AI tool Digistain revolutionizes breast cancer prognosis, saving lives and millions for NHS. #Digistain #BreastCancerPrognosis buff.ly/471cG0j